USP13 was shown to positively promote glycolysis and tumor progression by stabilizing and deubiquitinating METTL3, which is a well-known “writer” for m6A modification, at K488 by removing K48-linked ubiquitin chains. The gene discussed is USP13; the disease is neoplasm.